Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin PK/PD in PPROM
NCT04294069Phase 4Completed
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in preterm premature rupture of membranes (pPROM), sponsored by Thomas Jefferson University. Started Sep 2020; status: completed.
02
Drugs
azithromycin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT04294069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04294069.